1. Alterations in the Cellular Immune Compartment of Patients Treated with Third‐Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation1. (23rd August 2013) Authors: Jitschin, Regina; Mougiakakos, Dimitrios; Von Bahr, Lena; Völkl, Simon; Moll, Guido; Ringden, Olle; Kiessling, Rolf; Linder, Stig; Le Blanc, Katarina Journal: Stem cells Issue: Volume 31:Number 8(2013:Aug.) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. Issue 4 (4th September 2014) Authors: Kolosenko, Iryna; Fryknäs, Mårten; Forsberg, Sofi; Johnsson, Per; Cheon, HyeonJoo; Holvey‐Bates, Elise G.; Edsbäcker, Elin; Pellegrini, Paola; Rassoolzadeh, Hanif; Brnjic, Slavica; Larsson, Rolf; Stark, George R.; Grandér, Dan; Linder, Stig; Tamm, Katja Pokrovskaja; De Milito, Angelo Journal: International journal of cancer Issue: Volume 136:Issue 4(2015:Feb. 15) Page Start: E51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?. (July 2015) Authors: Selvaraju, Karthik; Mazurkiewicz, Magdalena; Wang, Xin; Gullbo, Joachim; Linder, Stig; D'Arcy, Pádraig Journal: Drug resistance updates Issue: Volume 21/22(2015) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control. (4th November 2015) Authors: Lundqvist, Andreas; Mao, Yumeng; Zhang, Xiaonan; Wennerberg, Erik; Van Hoef, Vincent; Larsson, Ola; Linder, Stig; Kiessling, Rolf Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control. Issue 2 (December 2015) Authors: Lundqvist, Andreas; Mao, Yumeng; Zhang, Xiaonan; Wennerberg, Erik; Van Hoef, Vincent; Larsson, Ola; Linder, Stig; Kiessling, Rolf Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Keratin‐18 and microRNA‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts. (14th October 2013) Authors: Thulin, Petra; Nordahl, Gunnar; Gry, Marcus; Yimer, Getnet; Aklillu, Eleni; Makonnen, Eyasu; Aderaye, Getachew; Lindquist, Lars; Mattsson, C. Mikael; Ekblom, Björn; Antoine, Daniel J.; Park, B. Kevin; Linder, Stig; Harrill, Alison H.; Watkins, Paul B.; Glinghammar, Björn; Schuppe‐Koistinen, Ina Journal: Liver international Issue: Volume 34:Number 3(2014:Apr.) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Portoamides A and B are mitochondrial toxins and induce cytotoxicity on the proliferative cell layer of in vitro microtumours. (February 2020) Authors: Sousa, Maria Lígia; Ribeiro, Tiago; Vasconcelos, Vítor; Linder, Stig; Urbatzka, Ralph Journal: Toxicon Issue: Volume 175(2020) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation. (28th April 2019) Authors: Hillert, Ellin-Kristina; Brnjic, Slavica; Zhang, Xiaonan; Mazurkiewicz, Magdalena; Saei, Amir Ata; Mofers, Arjan; Selvaraju, Karthik; Zubarev, Roman; Linder, Stig; D'Arcy, Padraig Journal: Cancer letters Issue: Volume 448(2019) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Serum efficacy biomarkers for oncology. (February 2009) Authors: Linder, Stig; Alaiya, Ayodele Journal: Biomarkers in medicine Issue: Volume 3:Number 1(2009) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b‐AP15. (27th May 2015) Authors: Wang, Xin; D'Arcy, Pádraig; Caulfield, Thomas R.; Paulus, Aneel; Chitta, Kasyapa; Mohanty, Chitralekha; Gullbo, Joachim; Chanan‐Khan, Asher; Linder, Stig Journal: Chemical biology & drug design Issue: Volume 86:Number 5(2015:Nov.) Page Start: 1036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗